CanaFarma Investor Hits Embattled Execs With Civil Suit
An investor in cannabis company CanaFarma has filed a complaint against the company alleging securities fraud, saying CanaFarma and two of its executives misappropriated at least $4 million from investors for...To view the full article, register now.
Already a subscriber? Click here to view full article